Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial

@article{Moretti2018CombinedOC,
  title={Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial},
  author={C. Moretti and L. Guccione and P. Di Giacinto and I. Simonelli and C. Exacoustos and V. Toscano and C. Motta and V. de Leo and F. Petraglia and A. Lenzi},
  journal={The Journal of Clinical Endocrinology \& Metabolism},
  year={2018},
  volume={103},
  pages={824–838}
}
Context Hirsutism often occurs in women with polycystic ovary syndrome (PCOS). The efficacy of oral contraceptive pill (OCP) plus antiandrogens in the treatment of its severe expression is controversial due to the lack of randomized, double-blind, long-term studies. Objective The primary outcome was the reduction of hirsutism in PCOS women objectively measured by videodermoscopy on the androgen-sensitive skin areas assessed by the modified Ferriman and Gallwey (mF&G) total score, after 12… Expand
Oral bicalutamide for female pattern hair loss: A pilot study
New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men.
Treatment challenges in adult female acne and future directions
Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
Health considerations for transgender women and remaining unknowns: a narrative review
...
1
2
...

References

SHOWING 1-10 OF 70 REFERENCES
Management of Hirsutism
New alternative treatment in hirsutism: bicalutamide 25 mg/day
Modified Ferriman-Gallwey hirsutism score and androgen levels in Turkish women.
Treatment of hirsutism in women with flutamide.
...
1
2
3
4
5
...